CYP3A5 and lung cancer: So, we suspect that CYP3A5 may affect ROS/mTORC2/p-AKT (S473) signaling pathway and limiting MMP2/9 function by affecting mRNA splicing and protein synthesis, thereby affecting the occurrence of lung cancer.